Chronic Kidney Disease

Kidney disease is among the most common causes of both hyperkalemia and hypokalemia.

Chronic kidney disease (CKD)-associated pruritus is a systemic itch condition occurring with a high frequency and intensity in patients with CKD undergoing dialysis.

The lower the glomerular filtration rate, the lower the stage, the worse kidney disease is.

Below a certain GFR, clinically significant reductions in plasma glucose cannot be achieved with sodium-glucose transport protein 2 inhibitors.

How should pharmacists manage a patient with diabetes on metformin with GFR below 30?

The drug is an investigational oral hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI) for patients with anemia due to chronic kidney disease (CKD).

The FDA has approved finerenone for the treatment of adult patients with chronic kidney disease associated with type 2 diabetes.

The approval marks the first nonsteroidal mineralocorticoid receptor antagonist proven to significantly slow chronic kidney disease progression and reduce cardiovascular risk in individuals with chronic kidney disease associated with type 2 diabetes.

Patients receiving dialysis are required to receive their treatments in clinics multiple times a week, meaning they were unable to effectively self-isolate.

The approval of dapagliflozin is the most significant advancement in the treatment of chronic kidney disease in more than 20 years, according to a press release.

In an interview with Pharmacy Times, Bruce Mueller, PharmD, interim dean and professor of clinical pharmacy at the University of Michigan College of Pharmacy, said pharmacists are essential in providing the correct dosing to patients with kidney disease.

RG is a male patient aged 45 years who has arrived at the pharmacy to pick up his regular maintenance medications after recently losing 45 pounds in 3 months.

A new study found that it’s safe for patients with HIV to receive HIV-positive kidneys.

Why is this man gaining weight, instead of losing it, while taking a natural supplement?

Of 400 dialysis patients with the Vall d’Hebron University Hospital as reference in Barcelona, Spain, 21 contracted the coronavirus disease 2019 (COVID-19) and the mortality rate in this center was 24%, according to the opening presentation at the ERA-EDTA Congress conference.

Previous clinical trials have shown that SGLT2 inhibitors protect kidney, or renal, function among patients with T2D, but their effect on serious renal events in patients in real-world clinical practice remains unclear.

Study shows sleep apnea is significantly associated with increased risk of death among patients with advanced chronic kidney disease (CKD) and end-stage renal disease.

The new guidelines recommend dosing vancomycin to achieve an area under the curve to minimum inhibitor concentration (AUC/MIC) ratio of ≥ 400.

Excessive alcohol consumption can damage the liver, thereby increasing the load on the kidneys to filter the blood stream.

Top news of the week across the healthcare landscape.

Top news from across the health care landscape.

Todd Brothers, PharmD, BCCCP, BCPS, clinical assistant professor, University of Rhode Island, discusses what patients should know about medications that cause hyperkalemia. This video was filmed at the ASHP (American Society of Health-System Pharmacists) 54th Clinical Meeting & Exhibition in Las Vegas, Nevada.

Through the Automatic LifeStyle Advice platform, health service providers can integrate personal health trackers, allowing data to configure the optimal recommendation for diet, exercise, and daily health management.

Study findings presented at the American Society of Nephrology’s Kidney Week 2019 suggest a link between chronic use of proton pump inhibitors and progression of kidney function decline in chronic kidney disease.

Baclofen use, particularly at higher doses, may result in an increased risk of encephalopathy among patients with chronic kidney disease.

Todd Brothers, PharmD, BCCCP, BCPS clinical assistant professor, University of Rhode Island, discusses the role of pharmacists in assessing patients for hyperkalemia and in managing those with a chronic condition. This video was filmed at the ASHP (American Society of Health-System Pharmacists) 54th Clinical Meeting & Exhibition in Las Vegas, Nevada.

Patients with HIV who are diagnosed with chronic kidney disease have a higher burden of serious clinical events.

Jaclyn Harth, PharmD, clinical assistant professor, Fairleigh Dickinson School of Pharmacy, discusses the role of the health system pharmacist for patients with chronic hyperkalemia. This video was filmed at the ASHP (American Society of Health-System Pharmacists) 54th Clinical Meeting & Exhibition in Las Vegas, Nevada.

A recent study showed that effective lifestyle behavioral changes for patients with chronic kidney disease frequently involved education, goal setting, feedback, monitoring, and social support.

A retrospective cohort study was the second largest evaluation to date of sodium polystyrene sulphonate use and safety in patients with chronic kidney disease.